SEQENS and Novonesis announce strategic partnership for enhancing customer’s access to industrial biocatalytic processes
SEQENS and Novonesis announce strategic partnership for enhancing customer’s access to industrial biocatalytic processes within the Fine Chemicals market.
The SEQENS Group, a global leader in health, personal care, and specialty ingredients, is excited to announce a strategic partnership with Novonesis, a world leader in sustainable biological solutions. Protéus teams within SEQENS* have developed a long-standing expertise in enzyme discovery, optimization, and production as well as biocatalytic process development and implementation. With the world’s largest strain bank, a broad commercial portfolio and large-scale, state-of-the-art production facilities, Novonesis harness the power of enzymes to replace chemicals and metal catalysts, reduce waste and make industrial processes greener and more efficient.
This partnership will leverage the combined expertise of both companies to offer comprehensive screening of an extensive range of commercial enzymes from their respective catalogs.
SEQENS’ long-standing expertise in developing associated biocatalytic processes, coupled with their robust manufacturing capabilities across various global locations, will ensure delivery of strong process books and efficient supply of desired reaction products.
Together, SEQENS and Novonesis are committed to driving advancements in biocatalysis, providing sustainable and cost-effective solutions, and enhancing the overall value proposition for their customers.
“This unique partnership between SEQENS and Novonesis finally brings together two industry leaders that will deliver innovative and competitive biocatalytic processes to the Fine Chemicals market” says Julien Boutet, Innovation & Biotechnologies Director at SEQENS.
“Novonesis and SEQENS, as strategic partners, will advance the Fine Chemical industry’s commitment to sustainability and innovation by successfully commercializing biocatalytic concepts” says Hans Ole Klingenberg, Vice President, Global Marketing & Strategy, House Hold Care & Industrial at Novonesis.
About Novonesis:
Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we help transform the way the world produces, consumes and lives. In more than 30 industries, our biosolutions are already creating value for thousands of customers and benefiting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology.
Novonesis was formed in 2024 when Chr. Hansen and Novozymes joined forces. Our biosolutions enable feeding and fueling the world more sustainably, and reduce the use of fossil-based resources, chemicals, energy and water. In Novonesis, we know that solutions rooted in biology can help solve humanity’s biggest challenges. Now, more than ever, the world needs change. And with biosolutions, the possibilities for transformation are endless.
We’re here to better our world with biology.
Discover our biosolutions for every application !
* SEQENS refers to the legal entity PCAS SAS